At AbsTech, our mission is to decrease patient harm and increase the therapeutic success of chemotherapies. We are developing a next-generation drug delivery platform that outperforms current solutions, enabling more effective and safer treatments for patients with solid tumours.
Better Patient Outcomes: Our proprietary delivery system aims to reduce chemotherapy toxicity by up to tenfold, improving patient quality of life.
Efficiency & Affordability: Designed for faster, more cost-effective development, our platform is applicable to a broad range of solid tumor treatments.
Partner-Friendly: We offer attractive strategic opportunities for pharmaceutical companies looking to enhance the therapeutic index of their existing therapies.
Founders:
Dr. Simon Beaudoin, PhD: A biochemistry researcher, serial inventor, and entrepreneur with a proven track record in guiding therapies through clinical development.
Ben Kachkowski Weiser: Expert in AI-driven computational chemistry, with startup experience in drug discovery optimization.
Adam Dufour: A specialist in antibody-based therapeutics and pharmaceutical chemistry, with a history of driving early-stage biotech ventures forward.
Contact for Partnerships or Investment:
To learn more about partnership or investment opportunities, please reach out to adam.dufour@abstech-sci.com.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Montréal & Sherbrook, Quebec, Ca
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Oncology, Drug Delivery, Chemotherapy.
- HQ
- Montréal & Sherbrook, Quebec
Abstech Questions
Abstech's LinkedIn profile is https://ca.linkedin.com/company/abstech-science
Abstech has
3 employees.
View email and phone details for 3
employees at Abstech.
Abstech's industry is
Biotechnology Research
Abstech's top competitors are
Bioalert Solutions,
Recability,
Ova Health Inc.,
Alaagi,
Luna,
Tissuetinker,
Tinybox Systems,
Hop Tech,
Diagen Ai,
Qalam Health Solutions.
Abstech's categories are Biotechnology Research
Abstech's founding year is 2024
